Douglas Karas - 29 Sep 2023 Form 4 Insider Report for Nascent Biotech Inc. (NBIO)

Role
Director
Signature
/s/ Douglas Karas
Issuer symbol
NBIO
Transactions as of
29 Sep 2023
Transactions value $
$4,969
Form type
4
Filing time
09 Nov 2023, 14:22:19 UTC
Previous filing
09 Jun 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBIO Common Stock Other $4,969 +39,750 +2.37% $0.1250* 1,715,517 29 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as part of the employment contract with the Company.